Unknown

Dataset Information

0

High-density lipoproteins suppress A?-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture.


ABSTRACT:

Background

Alzheimer's Disease (AD), characterized by accumulation of beta-amyloid (A?) plaques in the brain, can be caused by age-related failures to clear A? from the brain through pathways that involve the cerebrovasculature. Vascular risk factors are known to increase AD risk, but less is known about potential protective factors. We hypothesize that high-density lipoproteins (HDL) may protect against AD, as HDL have vasoprotective properties that are well described for peripheral vessels. Epidemiological studies suggest that HDL is associated with reduced AD risk, and animal model studies support a beneficial role for HDL in selectively reducing cerebrovascular amyloid deposition and neuroinflammation. However, the mechanism by which HDL may protect the cerebrovascular endothelium in the context of AD is not understood.

Methods

We used peripheral blood mononuclear cell adhesion assays in both a highly novel three dimensional (3D) biomimetic model of the human vasculature composed of primary human endothelial cells (EC) and smooth muscle cells cultured under flow conditions, as well as in monolayer cultures of ECs, to study how HDL protects ECs from the detrimental effects of A?.

Results

Following A? addition to the abluminal (brain) side of the vessel, we demonstrate that HDL circulated within the lumen attenuates monocyte adhesion to ECs in this biofidelic vascular model. The mechanism by which HDL suppresses A?-mediated monocyte adhesion to ECs was investigated using monotypic EC cultures. We show that HDL reduces A?-induced PBMC adhesion to ECs independent of nitric oxide (NO) production, miR-233 and changes in adhesion molecule expression. Rather, HDL acts through scavenger receptor (SR)-BI to block A? uptake into ECs and, in cell-free assays, can maintain A? in a soluble state. We confirm the role of SR-BI in our bioengineered human vessel.

Conclusion

Our results define a novel activity of HDL that suppresses A?-mediated monocyte adhesion to the cerebrovascular endothelium.

SUBMITTER: Robert J 

PROVIDER: S-EPMC5568306 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture.

Robert Jérôme J   Button Emily B EB   Stukas Sophie S   Boyce Guilaine K GK   Gibbs Ebrima E   Cowan Catherine M CM   Gilmour Megan M   Cheng Wai Hang WH   Soo Sonja K SK   Yuen Brian B   Bahrabadi Arvin A   Kang Kevin K   Kulic Iva I   Francis Gordon G   Cashman Neil N   Wellington Cheryl L CL  

Molecular neurodegeneration 20170822 1


<h4>Background</h4>Alzheimer's Disease (AD), characterized by accumulation of beta-amyloid (Aβ) plaques in the brain, can be caused by age-related failures to clear Aβ from the brain through pathways that involve the cerebrovasculature. Vascular risk factors are known to increase AD risk, but less is known about potential protective factors. We hypothesize that high-density lipoproteins (HDL) may protect against AD, as HDL have vasoprotective properties that are well described for peripheral ves  ...[more]

Similar Datasets

| S-EPMC5634784 | biostudies-literature
| S-EPMC4145050 | biostudies-literature
| S-EPMC7093966 | biostudies-literature
| S-EPMC7557107 | biostudies-literature
| S-EPMC3578265 | biostudies-literature
| S-EPMC10954247 | biostudies-literature
| S-EPMC3025507 | biostudies-literature
| S-EPMC5746473 | biostudies-literature
| S-EPMC2948973 | biostudies-literature
| S-EPMC2189725 | biostudies-literature